Citigroup Inc Veracyte, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Veracyte, Inc. stock. As of the latest transaction made, Citigroup Inc holds 60,777 shares of VCYT stock, worth $2.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

60,777

Previous 32,695 85.89%

Holding current value

$2.47 Million

Previous $708,000 192.09%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$21.0 - $35.25 $589,722 - $989,890	28,082 Added 85.89%	60,777 $2.07 Million
Q2 2024 Aug 12, 2024	SELL	$18.86 - $23.55 $4.54 Million - $5.67 Million	-240,713 Reduced 88.04%	32,695 $708,000
Q1 2024 May 10, 2024	BUY	$21.0 - $29.1 $4.13 Million - $5.73 Million	196,832 Added 257.04%	273,408 $6.06 Million
Q4 2023 Feb 09, 2024	SELL	$19.72 - $28.68 $362,650 - $527,425	-18,390 Reduced 19.36%	76,576 $2.11 Million
Q3 2023 Nov 09, 2023	BUY	$22.33 - $29.92 $7,056 - $9,454	316 Added 0.33%	94,966 $2.12 Million
Q2 2023 Aug 10, 2023	SELL	$20.96 - $26.99 $3.03 Million - $3.9 Million	-144,514 Reduced 60.42%	94,650 $2.41 Million
Q1 2023 May 11, 2023	BUY	$20.58 - $27.89 $2.26 Million - $3.06 Million	109,680 Added 84.71%	239,164 $5.33 Million
Q4 2022 Feb 09, 2023	SELL	$15.31 - $29.94 $2.94 Million - $5.74 Million	-191,716 Reduced 59.69%	129,484 $3.07 Million
Q3 2022 Nov 10, 2022	BUY	$16.58 - $27.9 $1.78 Million - $3 Million	107,552 Added 50.34%	321,200 $5.33 Million
Q2 2022 Aug 10, 2022	BUY	$15.45 - $29.52 $2.52 Million - $4.82 Million	163,273 Added 324.12%	213,648 $4.25 Million
Q1 2022 May 12, 2022	SELL	$21.94 - $42.51 $1.76 Million - $3.41 Million	-80,229 Reduced 61.43%	50,375 $1.39 Million
Q4 2021 Feb 10, 2022	BUY	$36.09 - $53.79 $2.04 Million - $3.04 Million	56,607 Added 76.5%	130,604 $5.38 Million
Q3 2021 Nov 10, 2021	BUY	$35.62 - $52.97 $2.64 Million - $3.92 Million	73,997 New	73,997 $3.44 Million

Others Institutions Holding VCYT

# of Institutions

311

Shares Held

81.6M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.9B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account